Moloney Securities Asset Management, LLC Ab Cellera Biologics Inc. Transaction History
Moloney Securities Asset Management, LLC
- $664 Million
- Q1 2025
A detailed history of Moloney Securities Asset Management, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 14,400 shares of ABCL stock, worth $37,584. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,400
Previous 90,400
84.07%
Holding current value
$37,584
Previous $264,000
87.88%
% of portfolio
0.0%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding ABCL
# of Institutions
167Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$71.8 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$31.9 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$27.7 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$20.7 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$19.2 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $744M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...